登录 注册 会员服务 联系我们

Case Examples of Using Quantitative Pharmacology in Developing Therapeutic Proteins in Multiple Sclerosis - Peginterferon Beta-1a, Daclizumab Beta, Natalizumab

  • Published:2019-02-15 Issue: Volume: Page:401-436
  • ISSN:
  • Container-title:Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases
  • language:
  • Short-container-title:

Author:

Hu Xiao12,Hang Yaming13,Diao Lei14,Muralidharan Kumar K.1,Nestorov Ivan1

Affiliation:

1. Biogen; 225 Binney Street Cambridge MA 02142 USA

2. Wave Life Sciences; 733 Concord Ave Cambridge MA 02138 USA

3. Takeda Pharmaceuticals International Co.; Cambridge MA 02138 USA

4. BMS China; 15F, Wheelock Square, 1717 West Nanjing Road Shanghai China

Publisher

John Wiley & Sons, Inc.

Reference71 articles.

1. Sex ratio of multiple sclerosis in Canada: a longitudinal study;Orton;Lancet Neurol.,2006

2. Disability in multiple sclerosis: a reference for patients and clinicians;Kister;Neurology,2013

3. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000;Mayr;Neurology,2003

4. Hersh , C.M. Fox , R.J. 2015 Multiple sclerosis http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/neurology/multiple_sclerosis/

5. European Medicines Agency 2015 Guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis http://www.thehumanmotioninstitute.org/sites/default/files/WC500185161.pdf
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3